Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
55.50    -0.50 (-0.89%)
Bid:
55.00
Ask:
56.00
Spread: 1.00 (1.818%)
Market Cap: £8.45m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Further Update

21 Nov 2007 07:30

Transense Technologies PLC21 November 2007 Transense Technologies plc ("Transense" or the "Company") Further update Further to the Company's announcement on 16 November 2007, the Company has nowcompleted its assessment of its position and is pleased to announce that it hastoday entered into a subscription agreement with Peter Lobbenberg, an existingshareholder in the Company, for the subscription (either by himself or throughconnected persons) of 1,043,500 Ordinary Shares in the Company at 23 pence pershare, raising a total of £240,005 for the Company. The proposed subscriptiondoes not require shareholder approval, is unconditional and is expected tocomplete within the next 10 business days. Peter Lobbenberg has notified theCompany that (excluding the Ordinary Shares to be acquired pursuant to thissubscription) he is currently interested in 2,625,936 Ordinary Shares in theCompany, representing 4.62% of its issued share capital. The Directors believethat this subscription will mean that, in the absence of unforeseencircumstances, the Company will have sufficient working capital until the end ofFebruary 2008. The Company is now seeking to undertake an additional fundraising before theyear end. To this end, discussions with certain shareholders of the Company(including Peter Lobbenberg), who have indicated they would support afundraising for in excess of £3 million of Ordinary Shares at a minimum of 23pence per Ordinary Share, are progressing well. The Company is working tofinalise this expeditiously although final legal documentation has yet to beagreed and the details have not yet been discussed with the Company's financialadvisers. Shareholder approval by way of a special resolution will be requiredfor such fundraising. Failure to effect such an additional fundraising beforethe end of February 2008 could result in the Company having to cease operations. The Company is now focusing on securing this fundraising and on its currenttrading activities. A further update on the fundraising will be announced indue course and the Company expects that trading in its shares will recommenceimmediately. Enquiries: Transense Technologies plc 01869 238 380Jim Perry / Peter Woods Noble & Company Limited 020 7763 2200John Llewellyn-Lloyd / Graeme Bayley This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th Dec 20201:19 pmRNSResult of AGM
17th Dec 20207:00 amRNSAGM Update, new Website & Investor Presentation
9th Dec 20207:00 amRNSEstablishment of SAW Commercial Advisory Panel
23rd Nov 20207:00 amRNSPosting of Annual Report and Notice of AGM
6th Nov 20203:38 pmRNSDirector/PDMR Shareholding
22nd Oct 20208:45 amRNSHolding(s) in Company
20th Oct 202012:09 pmRNSDirector/PDMR Shareholding
20th Oct 20207:00 amRNSFinal results for the year ended 30 June 2020
19th Oct 20207:00 amRNSChange of Nomad and Broker & AIM Rule 17 update
12th Oct 20207:00 amRNSNotice of Results and Investor Presentation
10th Sep 20207:00 amRNSFinal consideration for iTrack transfer
25th Aug 202010:23 amRNSDirector/PDMR Shareholding
24th Aug 20209:27 amRNSHolding(s) in Company (Replacement)
20th Aug 20205:02 pmRNSHolding(s) in Company
8th Jul 20204:16 pmRNSDirector/PDMR Shareholding
7th Jul 20203:38 pmRNSHolding(s) in Company
3rd Jul 202011:30 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSInvestor Presentation
1st Jul 20206:12 pmRNSHolding(s) in Company
26th Jun 20201:54 pmRNSDirector/PDMR Shareholding
26th Jun 20207:00 amRNSGrant of Options/PDMR Dealing
25th Jun 20204:41 pmRNSDirector/PDMR Shareholding
25th Jun 20202:10 pmRNSDirector/PDMR Shareholding
25th Jun 20207:01 amRNSStrategic Update
25th Jun 20207:00 amRNSBridgestone Granted Worldwide iTrack Licence
12th Jun 202010:40 amRNSUpdate relating to the JCA with Bridgestone
1st Jun 20207:00 amRNSUpdate relating to the JCA with Bridgestone
5th May 20202:39 pmRNSHolding(s) in Company
1st May 20207:00 amRNSUpdate relating to the JCA with Bridgestone
16th Mar 20207:00 amRNSFurther Working Capital Loan Agreement
20th Feb 20207:00 amRNSInterim Results
20th Feb 20207:00 amRNSInterim Results
19th Feb 20207:00 amRNSChanges to Board responsibilities
13th Feb 20207:01 amRNSNotice of Interim Results
13th Feb 20207:00 amRNSExtension to Agreement with Bridgestone
19th Dec 20194:14 pmRNSResult of AGM
19th Dec 20197:00 amRNSAGM Statement
19th Nov 20197:00 amRNSNotice of AGM
15th Nov 20194:53 pmRNSHolding(s) in Company
7th Nov 20191:13 pmRNSHolding(s) in Company
26th Sep 20197:00 amRNSFinal results for the year ended 30 June 2019
14th Aug 20199:09 amRNSHolding(s) in Company
13th Aug 20192:45 pmRNSAwards of Options
13th Aug 20197:00 amRNSJoint Collaboration Agreement with Bridgestone
30th Jul 20197:00 amRNSTrading Update
1st Jul 201912:02 pmRNSHolding(s) in Company
30th Apr 20194:10 pmRNSHolding(s) in Company
29th Apr 20198:52 amRNSHolding(s) in Company
26th Apr 20191:42 pmRNSHolding(s) in Company
4th Apr 201910:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.